Identification of Pulmonary Arterial Hypertension Patients with Venous or Capillary Involvement
Listen to this summary
The authors aimed to develop a likelihood score to distinguish patients with pulmonary arterial hypertension (PAH) who have features of venous or capillary involvement (PVOD/PCH) from those with other forms of PAH. By analyzing clinical variables from existing literature, they created a score that demonstrated high accuracy in identifying PVOD/PCH, which could improve early diagnosis, management, and expedite lung transplant referrals for affected patients.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from American journal of respiratory and critical care medicine
View all →Jun 12, 2026 · American journal of respiratory and critical care medicine
Defining disease stability in COPD: Evidence from Phase 3 clinical trials
Jun 11, 2026 · American journal of respiratory and critical care medicine
Association of White Blood Cell Count with Treatment Response to Cefepime vs Piperacillin-Tazobactam
More in Internal Medicine
View all →Jun 25, 2026 · Blood
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial
Jun 25, 2026 · Blood
Translational Regulation of Sf1 Integrates Alternative Splicing and Hematopoietic Stem Cell Fate
Jun 25, 2026 · Blood
Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms
Jun 25, 2026 · The American journal of sports medicine
Association of Central Acetabular Osteophytes With Microinstability and Increased Combined Anteversion in Borderline Dysplasia Hips
Jun 25, 2026 · Blood
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
